Huang Pardee, in 1999 [107], reported that β-lapachone had the ability to drastically reduce levels of mutant p53 in colon cancer cells, although it did not alter the expression levels of wild-type p53. The gene discussed is TP53; the disease is malignant colon neoplasm.